Raymon Hanna, DPM
Foot & Ankle Surgery · Palm Harbor, FLNPI 1518371616
Payments from drug & device makers
What this record shows
This record is dominated by other: $43,983 of the $50,747 with a category attached, or 86.7%. Smith+Nephew accounts for 87.3% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $34,898 and has fallen 98.0% since, to $689 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $502.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$44K
- Arthrex$3K
- Orthofix Medical, Inc.$1K
- Paragon 28, Inc.$1K
- Integra Lifesciences Corporation$402
- Stryker$390
- plus $724 from 17 others
What the payments were for
- Travel & lodging$2,2304%
- Food & beverage$1,9534%
- Education$2,5805%
- Other$43,98387%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 27 | $44,286 |
| Arthrex | 14 | $2,879 |
| Orthofix Medical, Inc. | 10 | $1,033 |
| Paragon 28, Inc. | 5 | $1,032 |
| Integra Lifesciences Corporation | 5 | $402 |
| Stryker | 5 | $390 |
| Organogenesis Inc. | 4 | $107 |
| KCI USA, Inc. | 4 | $77 |
| Amgen(2 entities) | 3 | $64 |
| Paratek Pharmaceuticals, Inc. | 4 | $63 |
| Solventum Corporation | 2 | $54 |
| Acera Surgical, Inc. | 3 | $53 |
| Kerecis Limited | 2 | $52 |
| Convatec Inc. | 3 | $49 |
| Acumed LLC | 2 | $38 |
| Avita Medical Americas, LLC | 1 | $36 |
| Johnson & Johnson | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Coastal Medical Technologies LLC | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Bsn Medical Inc | 1 | $16 |
| Triad Life Sciences Inc. | 1 | $14 |
| Hydrofera LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$43,676
- TrueLok$739
- INTEGRA$307
- PRIME SERIES$280
- Stravix$239
How this compares
$50,747 in reported general payments places this provider in the 90th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 16 | $5,469 |
| Ciclopirox | 18 | $451 |
| Doxycycline Hyclate | 54 | $311 |
| Ciprofloxacin Hcl | 14 | $100 |
| Cephalexin | 25 | $90 |
| Silver Sulfadiazine | 14 | $89 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $79 |
| Methylprednisolone | 11 | $57 |
| Meloxicam | 13 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $44,286 | $5,46916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in Palm Harbor
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
- Christopher ReevesLake Mary$424K
- Ettore VulcanoMiami Beach$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.